Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,959 | 865 | 98.8% |
| Education | $156.56 | 5 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,666 | 218 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,176 | 49 | $0 (2024) |
| GlaxoSmithKline, LLC. | $793.57 | 58 | $0 (2024) |
| Novo Nordisk Inc | $737.93 | 58 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $722.15 | 46 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $615.06 | 33 | $0 (2024) |
| PFIZER INC. | $485.83 | 42 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $470.20 | 33 | $0 (2024) |
| Mylan Specialty L.P. | $430.54 | 23 | $0 (2024) |
| Amgen Inc. | $384.07 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,494 | 206 | ABBVIE INC. ($649.93) |
| 2023 | $3,300 | 207 | ABBVIE INC. ($532.86) |
| 2022 | $3,009 | 214 | ABBVIE INC. ($697.00) |
| 2021 | $3,312 | 243 | AbbVie Inc. ($786.39) |
All Payment Transactions
870 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Neurology | ||||||
| 12/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: UROLOGY | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/13/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Oncology | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Respiratory | ||||||
| 12/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.68 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $43.14 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: Cardio-renal | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.42 | General |
| Category: PAIN | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $34.21 | General |
| Category: Oncology | ||||||
| 11/01/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 519 | 888 | $95,395 | $38,891 |
| 2022 | 12 | 387 | 795 | $88,064 | $36,610 |
| 2021 | 10 | 347 | 814 | $89,791 | $35,649 |
| 2020 | 14 | 540 | 984 | $104,823 | $36,296 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 117 | 427 | $55,510 | $20,220 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 72 | 72 | $14,400 | $7,325 | 50.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 63 | $12,600 | $4,131 | 32.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 41 | 62 | $2,666 | $2,003 | 75.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 24 | 24 | $1,800 | $1,761 | 97.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 72 | 72 | $2,520 | $1,039 | 41.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 31 | 31 | $930.00 | $887.53 | 95.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 12 | $852.00 | $357.50 | 42.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 15 | 23 | $920.00 | $312.69 | 34.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 18 | 19 | $665.00 | $249.28 | 37.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 20 | 22 | $770.00 | $209.44 | 27.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 14 | 14 | $420.00 | $172.90 | 41.2% |
| 98966 | Telephone medical discussion provided by nonphysician professional, 5-10 minutes | Office | 2023 | 17 | 19 | $950.00 | $127.80 | 13.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 28 | $392.00 | $95.48 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 120 | 460 | $59,800 | $22,564 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 57 | 57 | $11,400 | $5,945 | 52.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 41 | $8,200 | $3,362 | 41.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 31 | 44 | $1,892 | $1,489 | 78.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 46 | 46 | $1,610 | $666.53 | 41.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 14 | 19 | $1,140 | $659.92 | 57.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 20 | $1,420 | $651.45 | 45.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 12 | 32 | $800.00 | $521.02 | 65.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $360.00 | $327.80 | 91.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 12 | 12 | $420.00 | $157.85 | 37.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 12 | 14 | $490.00 | $134.30 | 27.4% |
About Michelle Vissing, APRN
Michelle Vissing, APRN is a Family healthcare provider based in Jeffersonville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2019. The National Provider Identifier (NPI) number assigned to this provider is 1740849637.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michelle Vissing, APRN has received a total of $13,115 in payments from pharmaceutical and medical device companies, with $3,494 received in 2024. These payments were reported across 870 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($12,959).
As a Medicare-enrolled provider, Vissing has provided services to 1,793 Medicare beneficiaries, totaling 3,481 services with total Medicare billing of $147,446. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Jeffersonville, IN
- Active Since 06/13/2019
- Last Updated 08/20/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1740849637
Products in Payments
- VRAYLAR (Drug) $1,408
- BREZTRI (Drug) $849.60
- HETLIOZ (Drug) $699.74
- UBRELVY (Drug) $642.21
- TRELEGY ELLIPTA (Drug) $624.81
- TRINTELLIX (Drug) $569.56
- NURTEC ODT (Drug) $533.89
- CAPLYTA (Drug) $520.90
- Kerendia (Drug) $470.20
- Auvelity (Drug) $359.29
- GEMTESA (Drug) $358.79
- REXULTI (Drug) $327.07
- Ozempic (Drug) $308.14
- Aimovig (Biological) $270.89
- QULIPTA (Drug) $254.43
- Rybelsus (Drug) $243.18
- Yupelri (Drug) $216.65
- YUPELRI (Drug) $213.89
- LINZESS (Drug) $211.79
- Cologuard Collection Kit (Device) $183.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Jeffersonville
Stacy Garcia, Aprn, APRN
Family — Payments: $13,689
Ms. Karona Yarbrough, Fnp-C, FNP-C
Family — Payments: $6,070
Allison Beavers, Aprn, APRN
Family — Payments: $5,376
Amanda Davis-Houchen, Fnp-C, FNP-C
Family — Payments: $4,422
Aimee Knott, Fnp, FNP
Family — Payments: $4,167
Ms. Sabina Sisic, Aprn, APRN
Family — Payments: $4,106